Hypertension,Essential: Clinical Trials

4 trials for Hypertension,Essential, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Recruiting 1

Follow Hypertension,Essential: new trials by email Literature Review of Hypertension,Essential trials Research Report on Hypertension,Essential

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
Songling Xuemaikang Capsules, Lifestyle intervention, Placebo - Hypertension,Essential
Phase 4RecruitingXiyuan Hospital of China Academy of Chinese Medical Sciences1002024-04-072024-08-20
Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With Hyperuricemia
Aliskiren, Losartan - Hypertension,Essential, Hyperuricemia
Phase 4CompletedHansung University662021-05-012024-12-05
Antiplatlet Effects of Standardized Tomato Extract in Hypertensive Subjects
acetylsalicylic acid, Tomato Fruit Extract - Hypertension,Essential, Obesity
Phase 4CompletedBeata Krasinska822015-07-012017-07-02
Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy
Eplerenone 50 mg Tab - Hypertension,Essential, Obstructive Sleep Apnea
Phase 4CompletedPoznan University of Medical Sciences1252014-07-012017-06-14

Narrower conditions

Essential Hypertension (4)  ·  Hypertension (1)  ·  Hypertrophy, Left Ventricular (1)  ·  Hyperuricemia (1)  ·  Obesity (1)  ·  Sleep Apnea, Obstructive (1)  ·  Vascular Remodeling (1)

Broader conditions

Cardiovascular Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Vascular Diseases (4)  ·  Hypertension (3)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Anatomical (2)  ·  Apnea (1)  ·  Body Weight (1)  ·  Cardiomegaly (1)  ·  Dyssomnias (1)  ·  Heart Diseases (1)  ·  Hypertrophy (1)  ·  Nervous System Diseases (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Aspirin (1)  ·  Eplerenone (1)  ·  Losartan (1)  ·  aliskiren (1)  ·  songling xuemaikang (1)

Sponsors

Beata Krasinska (1)  ·  Hansung University (1)  ·  Poznan University of Medical Sciences (1)  ·  Xiyuan Hospital of China Academy of Chinese Medical Sciences (1)

Countries

China (2)

Top investigators

Andrzej Tykarski, Prof (2)  ·  Hao Xu, Prof. (1)  ·  Szczepan Cofta, PhD (1)

Results publications

PMID 10450601, PMID 10678860, PMID 10908222, PMID 10940788, PMID 11010931, PMID 11208620, PMID 11422885, PMID 11454256, PMID 15867308, PMID 16376782, PMID 16960170, PMID 16960171, PMID 17494787, PMID 17921053, PMID 1798888, PMID 18404673, PMID 18458174, PMID 19482214, PMID 20016520, PMID 20411620, PMID 23069270, PMID 23317928, PMID 24048285, PMID 24107724, PMID 25469376, PMID 26208670, PMID 26307961, PMID 26363438, PMID 26781788, PMID 26840280, PMID 2698218, PMID 27388464, PMID 28122885, PMID 28290077, PMID 2936235, PMID 40770317